Reneo Pharmaceuticals posts updated corporate slide deck for investor meetings

OnKure Therapeutics, Inc.

Presentation available on company website and filed as Exhibit 99.1 to Form 8-K.
Deck highlights focus on rare genetic mitochondrial diseases.
No specific financial or clinical data disclosed in the filing itself.

item 7.01 item 9.01

OnKure Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-21-011217

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.